Transdermal CNS Therapeutics to 2028

“Transdermal CNS Therapeutics to 2028: Products, Therapeutics, Markets and Forecasts” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, patch designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for Transdermal patches Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Converging Factors Driving Growth in Transdermal Delivery

Transdermal CNS drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2028.

What You Will Learn:

• Analyzes and evaluates current transdermal CNS therapeutics markets and products and assesses the market potential for existing and probable future products

• Analyzes patch designs, technologies and patch development issues

• Profiles patch manufacturers and third-party transdermal supply chain companies

• Provides detailed assessments of more than a dozen products in more than a dozen product categories

• Provides market data and forecasts to 2028

• Profiles transdermal drug patch product providers, their product development activity, and strategies

• Evaluates the impact of economic, technology, and regulatory factors